SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CCA8060BA79F79BA28F34F255ACD3A3E11E185AEDA7CA7B060873B606291832B060C07CDC474B99C9DC7F5568863BA24>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CCA8060BA79F79BA28F34F255ACD3A3E11E185AEDA7CA7B060873B606291832B060C07CDC474B99C9DC7F5568863BA24
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CCA8060BA79F79BA28F34F255ACD3A3E11E185AEDA7CA7B060873B606291832B060C07CDC474B99C9DC7F5568863BA24
http://www.w3.org/2000/01/rdf-schema#comment
"Inhibition of ERalpha signaling in prostate cancer cells may be a novel therapeutic strategy to inhibit the osteoblastic lesion development as well as lung metastasis in patients with advanced prostate cancer."
xsd:string
http://purl.uniprot.org/uniprot/#_D41DFCD784EE1EB3BF38B7A924711FE2E0DE1AD10444199C0120C2FD662079E0E90D1EEE8505A7626EDA7EE93EDD255D
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CCA8060BA79F79BA28F34F255ACD3A3E11E185AEDA7CA7B060873B606291832B060C07CDC474B99C9DC7F5568863BA24
http://purl.uniprot.org/uniprot/Q9H2M1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CCA8060BA79F79BA28F34F255ACD3A3E11E185AEDA7CA7B060873B606291832B060C07CDC474B99C9DC7F5568863BA24
http://purl.uniprot.org/uniprot/#_Q9H2M1-mappedCitation-26575018
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CCA8060BA79F79BA28F34F255ACD3A3E11E185AEDA7CA7B060873B606291832B060C07CDC474B99C9DC7F5568863BA24